University of Colorado, Denver

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Colorado, Denver sits in the top decile of US sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count).

1,283 total trials 265 currently recruiting 830 completed early-phase tilt top decile by trial count

University of Colorado, Denver: 1,283 sponsored US clinical trials, 265 recruiting.

University of Colorado, Denver sponsors 1,283 registered US clinical trials on ClinicalTrials.gov, 265 of them currently recruiting, and 830 completed. 121 of these trials are in Phase 3-4 (later-stage) and 245 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 23 trials.

Top-decile sponsor footprint

University of Colorado, Denver ranks in the top decile of sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 68/100

830 of 908 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,283 total, page 18 of 26

COMPLETED

Effects of EED on Zn Absorption and Retention in Children From a Standard Dose

NCT02760095

COMPLETED NA

Insular Inhibitory Neuromodulation to Reduce Cigarette Craving and Alter Brain Function in Smokers

NCT02590640

COMPLETED NA

PTH And Calcium Responses to Exercise in Older Adults Experiment 2 (PACE Sr. 2)

NCT02580604

COMPLETED Phase 1

A Study of Eribulin in Combination With Oral Irinotecan for Adolescent and Young Adult Patients With Relapsed or Refractory Solid Tumors

NCT02596503

COMPLETED NA

Depressed AIRE Gene Expression Causes Immune Cell Dysfunction & Autoimmunity in Down Syndrome

NCT02421276

COMPLETED Phase 1

The Immuno-Response to Primary Cryotherapy for the Treatment of Prostate Cancer

NCT02250014

COMPLETED NA

Southwest Health Extension Partnership to Enhance Research Dissemination

NCT02515578

COMPLETED NA

Partnership to Improve Nutrition and Adiposity in Prenatal Clinical Care: a Pilot and Feasibility Study

NCT02520167

COMPLETED NA

A Couples-based Approach for Increasing Physical Activity Among Adults With Type 2 Diabetes

NCT02579395

COMPLETED

Sleep Timing and Insulin Resistance in Adolescents With Obesity

NCT02585830

COMPLETED NA

Does Outpatient Palliative Care Improve Patient-centered Outcomes in Parkinson's Disease?

NCT02533921

COMPLETED NA

Improving Quality of Life in Heart Failure

NCT03288194

COMPLETED NA

An Intervention to Increase Engagement With Hypertension Care for American Indian Patients

NCT04414982

COMPLETED

User Testing and Feedback for a Mobile Health Program for Postpartum Women: A Pilot Study

NCT02384226

COMPLETED Phase 2

Bromocriptine Quick Release (BCQR) as Adjunct Therapy in Type 1 Diabetes

NCT02544321

COMPLETED NA

The Beef WISE Study: Beef's Role in Weight Improvement, Satisfaction, and Energy

NCT02627105

COMPLETED NA

Effects of Acetate and Alcohol on Brain Function

NCT02542150

COMPLETED NA

Comparison of Epidural and Paracostal Catheter Placement for Pain Control After Rib Fractures

NCT02295098

COMPLETED Phase 4

Three New Ideas to Protect Special Forces From the Stress of High Altitude

NCT02463357

COMPLETED NA

Pilot Prospective CGM Quality Improvement (QI) Project in Pregnancy

NCT02556554

COMPLETED

Cardiac Remodeling and Circulating Biomarkers in Pediatric Left Ventricular Pressure Loading Lesions

NCT02545790

COMPLETED NA

PTH And Calcium Responses to Exercise (PACE) in Older Adults

NCT02468817

COMPLETED

Study of Hepatic Responses in Patients Receiving Direct-acting Anti-HCV Drugs

NCT02532907

COMPLETED

Pilot Project to Examine the Effects of Exercise on Nocturnal Lipolysis in Men and Women

NCT02408510

TERMINATED NA

Transcranial Treatments in Eating Disorders

NCT02535780

COMPLETED NA

Trial of Diet in Gestational Diabetes Mellitus: Metabolic Consequences to Mother and Offspring

NCT02244814

COMPLETED NA

Dysregulation of FSH in Obesity: Functional and Statistical Analysis

NCT02478775

TERMINATED NA

Impact of Daylight on Patients With Acute Myocardial Infarction

NCT02490397

COMPLETED NA

Fast MR for Young Children With Traumatic Brain Injury

NCT02392975

COMPLETED NA

Expandability of Aging Adipose Tissue

NCT02456870

TERMINATED Phase 1

Phase I Nicotinic Agonist Treatment Trial for Autism

NCT02111551

COMPLETED NA

Tissue and Hematopoietic/Mesenchymal Stem Cell for Humanized Xenograft Studies in Melanoma and Squamous Head and Neck Cancer

NCT02331134

COMPLETED Phase 4

Body Composition in Infants With Klinefelter Syndrome and Effects of Testosterone Treatment

NCT02408445

COMPLETED NA

PCORI-1310-06998 Trial of a Decision Support Intervention for Patients and Caregivers Offered Destination Therapy Heart Assist Device

NCT02344576

COMPLETED NA

Simultaneous Improvement in Colon Cancer Screening Rates and Patient-Centered Care

NCT02377232

TERMINATED Phase 3

Reversal of Hepatic Impairment in Patients With Hepatitis C Virus (HCV) and Early Decompensation of Cirrhosis

NCT02455167

COMPLETED Phase 2

Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy

NCT02366871

COMPLETED NA

Dietary Supplementation to Increase Serum Choline Levels

NCT02403804

COMPLETED

Clinical Validation of a Predictive Model for the Presence of Cervical Lymph Node Metastasis in Papillary Thyroid Cancer

NCT02442661

COMPLETED NA

Exercise for Healthy Aging: The Impact of HIV and Aging on Physical Function and the Somatopause

NCT02404792

TERMINATED NA

Improving Physical Function in Skilled Nursing Facility Residents

NCT02421692

COMPLETED NA

Effect of Soy Protein and Colorado Diet on Weight Loss and Maintenance

NCT03248804

COMPLETED NA

Blood Flow Within Active Myofascial Trigger Points Following Massage

NCT02389140

COMPLETED NA

Intra Articular Injections With Platelet Rich Plasma in Patients With Juvenile Osteochondritis Dissecans of the Knee

NCT02397278

TERMINATED

Choroidal Thickness in Optic Neuropathy

NCT02382627

TERMINATED NA

Sequential Intravesical Bacillus Calmette-Guérin and Electromotive Mitomycin-C After Transuretheral Resection

NCT02202044

COMPLETED NA

Accountable Care Organizations/ Public Health Collaborative

NCT02133391

COMPLETED NA

Screening and Linkage to Services for Autism

NCT02374541

COMPLETED NA

Strengthening Physician Communication About HPV Vaccines

NCT02456077

COMPLETED Early Phase 1

Postpartum Hemorrhage Prevention in Patients With Preeclampsia (PHP3 Study)

NCT02221830

← Previous Page 18 of 26 Next →

Phase Distribution

PhaseTrial count
Phase 1 114
Phase 2 131
Phase 3 37
Phase 4 84

What is open in the University of Colorado, Denver pipeline

265 recruiting of 1,283 indexed (21% open); 830 completed (65%).

Phase mix: 121 late (III/IV) vs 245 early (I/II) (early-phase heavy).

Top condition: Obesity (23 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Colorado, Denver: open-pipeline peers nationwide

Peers matched on 1,283 registered trials and 21% open enrollment, not the therapeutic-area sidebar.

University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 5%10%15%20%25% Total trials Recruiting share University of Colorado, DenverAstraZenecaUniversity of MichiganUniversity of PittsburghEli Lilly and CompanyCedars-Sinai Medical CenterCraig HospitalW.L.Gore & AssociatesGeorgia Institute of Technology
University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,283 trials (± recruiting share)

Sponsors near 21% open enrollment (± trial volume)

What to do with this University of Colorado, Denver page

1,283 registered trials is a research-attention snapshot, not an endorsement of University of Colorado, Denver or any single study.

  • 265 of University of Colorado, Denver's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition University of Colorado, Denver studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Colorado, Denver pipeline card: 1,283 registered trials from official public datasets.Report a data error.